Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-28

Clinical Trial Update: Fluocinolone Acetonide Intravitreal Inserts for Vein Occlusion in Retina [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating fluocinolone acetonide intravitreal inserts for macular edema due to retinal vein occlusion was terminated; results were posted in 2015…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ILUVIEN (fluocinolone acetonide)

Snippet

Sponsor: Alimera Sciences | Conditions: Macular Edema, Retinal Vein Occlusion | Phase 2 | Status: TERMINATED | Results posted: 2015-05-28